3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Infections
2
Wound Infection
1
Surgical Wound Infection
1
Prostatic Neoplasms
1
Laryngeal Neoplasms
1
Bone Neoplasms
1
Interventions
Ibandronic Acid
4
Zoledronic Acid
3
Tranexamic Acid
2
ridaforolimus
1
dinutuximab
1
Sodium Pertechnetate Tc 99m
1
Sodium Chloride
1
Neutrons
1
Fluoridation
1
Fibrin Tissue Adhesive
1
Diathermy
1
Denosumab
1
Cyproheptadine
1
Cefazolin
1
Captopril
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Bone Neoplasms
×
Cefazolin
×
Clear all
NCT01479283
2021-03-11
PARITY
McMaster University
Phase 3
Completed
602 enrolled